Electronics & Pharma Secure 70% of FY25 PLI Funds: Govt Data
The Production Linked Incentive (PLI) scheme, launched by the Indian government in 2021, has been a significant boost to the country’s manufacturing sector. The scheme was designed to incentivize domestic production and attract investments in key sectors. According to official data, the electronics and pharma sectors have emerged as the top beneficiaries of the PLI scheme in FY25, securing nearly 70% of the total funds disbursed.
As per the data, the electronics sector received the largest chunk of funds, amounting to ₹5,732 crore, while the pharma sector received ₹2,328 crore. These two sectors collectively accounted for 70% of the total ₹10,114 crore disbursed under the PLI scheme in FY25.
The PLI scheme was initially rolled out for 14 key sectors, including textiles, food processing, pharmaceuticals, and electronics. The scheme offers incentives to eligible companies in the form of a percentage of their production value, subject to certain conditions.
The government’s decision to offer a significant proportion of the PLI funds to the electronics and pharma sectors is a testament to the importance it attaches to these sectors. The electronics sector, in particular, has been a key area of focus for the government, given its potential to drive economic growth and create jobs.
The electronics sector’s significant allocation of funds under the PLI scheme is a reflection of the government’s efforts to promote domestic manufacturing and reduce dependence on imports. The sector has seen significant growth in recent years, driven by increasing demand for electronic products in the country.
The pharma sector, on the other hand, has been a major contributor to India’s healthcare industry, accounting for over 3.5% of the country’s GDP. The sector’s allocation of funds under the PLI scheme is a recognition of its importance in providing affordable healthcare services to the country’s growing population.
The PLI scheme has been instrumental in attracting investments in these sectors, with many companies announcing new projects and expansions in recent months. The scheme’s success has also led to increased competition and innovation in the sectors, which is likely to benefit consumers in the long run.
While the PLI scheme has been a success, there are some concerns about its implementation. Some critics have argued that the scheme’s eligibility criteria are too restrictive, which has limited the number of companies that can participate. Others have raised concerns about the lack of transparency in the allocation of funds under the scheme.
Despite these concerns, the PLI scheme has the potential to be a game-changer for India’s manufacturing sector. The government’s decision to offer a significant proportion of the funds to the electronics and pharma sectors is a step in the right direction, and it is likely to have a positive impact on the country’s economy in the long run.
In conclusion, the data released by the government highlights the importance of the electronics and pharma sectors in India’s manufacturing landscape. The significant allocation of funds under the PLI scheme to these sectors is a recognition of their potential to drive economic growth and create jobs. While there are some concerns about the scheme’s implementation, its success has the potential to be a game-changer for India’s manufacturing sector.
Source:
